A carregar...
Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients
AIM: To evaluate the efficacy and safety of tolvaptan to treat refractory ascites in decompensated liver cirrhosis patients with or without further complications, such as hepatorenal syndrome and/or hepatocellular carcinoma. METHODS: Thirty-nine patients (mean age 55 years, males: 32) with decompens...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4145782/ https://ncbi.nlm.nih.gov/pubmed/25170228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i32.11400 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|